Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III)

References

• Hyde Z, Flicker L, Almeida OP, Hankey GJ, McCaul KA, Chubb SA, Yeap BB. Low free testosterone predicts frailty in older men: the health in men study. J Clin Endocrinol Metab 2010;95:3165–3172.
   PubMed Web of Science ®Google Scholar
• Ahmed N, Mandel R, Fain MJ. Frailty: an emerging geriatric syndrome. Am J Med 2007;120:748–753.
   PubMed Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, et al.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001;56:M146–M156.
   PubMed Web of Science ®Google Scholar
• Rockwood K, Hogan DB, MacKnight C. Conceptualisation and measurement of frailty in elderly people. Drugs Aging 2000;17:295–302.
   Google Scholar
• O’Connell MD, Tajar A, Roberts SA, Wu FC. Do androgens play any role in the physical frailty of ageing men? Int J Androl 2011;34:195–211.
   Google Scholar
• Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, Simonsick EM, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci 2006;61:1059–1064.
   PubMed Web of Science ®Google Scholar
• Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR; Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001;86:724–731.
   PubMed Web of Science ®Google Scholar
• Fantin F, Di Francesco V, Fontana G, Zivelonghi A, Bissoli L, Zoico E, Rossi A, et al. Longitudinal body composition changes in old men and women: interrelationships with worsening disability. J Gerontol A Biol Sci Med Sci 2007;62:1375–1381.
   PubMed Web of Science ®Google Scholar
• Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589–598.
   PubMed Web of Science ®Google Scholar
• Gielen E, Vanderschueren D, Callewaert F, Boonen S. Osteoporosis in men. Best Pract Res Clin Endocrinol Metab 2011;25:321–335.
   PubMed Web of Science ®Google Scholar
• van den Beld AW, Lamberts SW. The male climacterium: clinical signs and symptoms of a changing endocrine environment. Prostate Suppl 2000;10:2–8.
   Google Scholar
• Wu IC, Lin XZ, Liu PF, Tsai WL, Shiesh SC. Low serum testosterone and frailty in older men and women. Maturitas 2010;67:348–352.
   PubMed Web of Science ®Google Scholar
• Mohr BA, Bhasin S, Kupelian V, Araujo AB, O’Donnell AB, McKinlay JB. Testosterone, sex hormone-binding globulin, and frailty in older men. J Am Geriatr Soc 2007;55:548–555.
   PubMed Web of Science ®Google Scholar
• Cawthon PM, Ensrud KE, Laughlin GA, Cauley JA, Dam TT, Barrett-Connor E, Fink HA, et al.; Osteoporotic Fractures in Men (MrOS) Research Group. Sex hormones and frailty in older men: the osteoporotic fractures in men (MrOS) study. J Clin Endocrinol Metab 2009;94:3806–3815.
   PubMed Web of Science ®Google Scholar
• Travison TG, Nguyen AH, Naganathan V, Stanaway FF, Blyth FM, Cumming RG, Le Couteur DG, et al. Changes in reproductive hormone concentrations predict the prevalence and progression of the frailty syndrome in older men: the concord health and ageing in men project. J Clin Endocrinol Metab 2011;96:2464–2474.
   PubMed Web of Science ®Google Scholar
• Wilhelm-Leen ER, Hall YN, K Tamura M, Chertow GM. Frailty and chronic kidney disease: the Third National Health and Nutrition Evaluation Survey. Am J Med 2009;122:664–71.e2.
   PubMed Web of Science ®Google Scholar
• Statistics NCfH. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Series 1: programs and collection procedures. Vital Health Stat 1994;32:1–407.
   Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666–3672.
   PubMed Web of Science ®Google Scholar
• Rinaldi S, Geay A, Déchaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, Shore RE, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev 2002;11:1065–1071.
   PubMed Web of Science ®Google Scholar
• Shah B, Barnwell BG, Bieler GS, editor. SUDAAN User’s Manual: Software for Analysis of Correlated Data. NC: Research Triangle Institute; 1995.
   Google Scholar
• National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Series 1: programs and collection procedures; 1994. 1–407 p.
   Google Scholar
• Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006;91:1995–2010.
   PubMed Web of Science ®Google Scholar
• Greenspan F, editor. Basic and Clinical Endocrinology. 4th edn. Conneticut: East Norwalk; 1994.
   Google Scholar
• Rohrmann S, Shiels MS, Lopez DS, Rifai N, Nelson WG, Kanarek N, Guallar E, et al. Body fatness and sex steroid hormone concentrations in US men: results from NHANES III. Cancer Causes Control 2011;22:1141–1151.
   PubMed Web of Science ®Google Scholar
• Svartberg J, Jorde R. Endogenous testosterone levels and smoking in men. The fifth Tromsø study. Int J Androl 2007;30:137–143.
   PubMedGoogle Scholar
• Shiels MS, Rohrmann S, Menke A, Selvin E, Crespo CJ, Rifai N, Dobs A, et al. Association of cigarette smoking, alcohol consumption, and physical activity with sex steroid hormone levels in US men. Cancer Causes Control 2009;20:877–886.
   PubMed Web of Science ®Google Scholar
• Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, Forti G, et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 2011;165:687–701.
   PubMed Web of Science ®Google Scholar
• Abellan van Kan G, Rolland Y, Bergman H, Morley JE, Kritchevsky SB, Vellas B. The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging 2008;12:29–37.
   PubMed Web of Science ®Google Scholar
• Ensrud KE, Ewing SK, Taylor BC, Fink HA, Cawthon PM, Stone KL, Hillier TA, et al. Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. Arch Intern Med 2008;168:382–389.
   PubMed Web of Science ®Google Scholar
• Swerdloff RS, Wang C. Androgens and the ageing male. Best Pract Res Clin Endocrinol Metab 2004;18:349–362.
   PubMed Web of Science ®Google Scholar
• Herbst KL, Bhasin S. Testosterone action on skeletal muscle. Curr Opin Clin Nutr Metab Care 2004;7:271–277.
   PubMed Web of Science ®Google Scholar
• Tracz MJ, Sideras K, Boloña ER, Haddad RM, Kennedy CC, Uraga MV, Caples SM, et al. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab 2006;91:2011–2016.
   PubMed Web of Science ®Google Scholar
• Seftel A. Male hypogonadism. Part II: etiology, pathophysiology, and diagnosis. Int J Impot Res 2006;18:223–228.
   PubMed Web of Science ®Google Scholar
• Pagotto U, Gambineri A, Pelusi C, Genghini S, Cacciari M, Otto B, Castañeda T, et al. Testosterone replacement therapy restores normal ghrelin in hypogonadal men. J Clin Endocrinol Metab 2003;88:4139–4143.
   PubMed Web of Science ®Google Scholar
• Sih R, Morley JE, Kaiser FE, Perry HM 3rd, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 1997;82:1661–1667.
   PubMed Web of Science ®Google Scholar
• Asarian L, Geary N. Modulation of appetite by gonadal steroid hormones. Philos Trans R Soc Lond, B, Biol Sci 2006;361:1251–1263.
   PubMed Web of Science ®Google Scholar
• Ottenbacher KJ, Ottenbacher ME, Ottenbacher AJ, Acha AA, Ostir GV. Androgen treatment and muscle strength in elderly men: A meta-analysis. J Am Geriatr Soc 2006;54:1666–1673.
   PubMed Web of Science ®Google Scholar
• Krasnoff JB, Basaria S, Pencina MJ, Jasuja GK, Vasan RS, Ulloor J, Zhang A, et al. Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab 2010;95:2790–2799.
   PubMed Web of Science ®Google Scholar
• Srinivas-Shankar U, Roberts SA, Connolly MJ, O’Connell MD, Adams JE, Oldham JA, Wu FC. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010;95:639–650.
   PubMed Web of Science ®Google Scholar
• Morley JE, Kim MJ, Haren MT. Frailty and hormones. Rev Endocr Metab Disord 2005;6:101–108.
   PubMed Web of Science ®Google Scholar
• Ferrini RL, Barrett-Connor E. Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol 1998;147:750–754.
   PubMed Web of Science ®Google Scholar
• Khosla S, Melton LJ 3rd, Atkinson EJ, O’Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab 1998;83:2266–2274.
   PubMed Web of Science ®Google Scholar